Robert J Hugin's Net Worth

$285 Million

Estimate Recalculated Sep 10, 2024 09:03AM EST

Who is Robert J Hugin?

Robert J Hugin has an estimated net worth of $285 Million. This is based on reported shares across multiple companies, which include DANAHER CORP /DE/, Chubb Ltd, Coley Pharmaceutical Group, Inc., Biohaven Pharmaceutical Holding Co Ltd., Allergan plc, CELGENE CORP /DE/, Biohaven Ltd., and MEDICINES CO /DE.

SEC CIK

Robert J Hugin's CIK is 0001232505

Past Insider Trading and Trends

2005 was Robert J Hugin's most active year for acquiring shares with 43 total transactions. Robert J Hugin's most active month to acquire stocks was the month of April. 2005 was Robert J Hugin's most active year for disposing of shares, totalling 37 transactions. Robert J Hugin's most active month to dispose stocks was the month of August. 2013 saw Robert J Hugin paying a total of $12,108,074.58 for 684,321 shares, this is the most they've acquired in one year. In 2014 Robert J Hugin cashed out on 1,684,101 shares for a total of $83,265,175.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DANAHER CORP /DE/ (DHR) Snapshot price: $266.2

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+38.28%
990
—
—
3.58K
May 15
Form 4/A
+60.02%
970
—
—
2.59K
Jul 15
Form 3/A
—
0
—
—
0
Form 4
∞
970
—
—
970
Jul 15
Form 3
—
0
—
—
0
No matching records found

Chubb Ltd (CB) Snapshot price: $286.0208

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+6.82%
1.23K
—
—
19.21K
May 16
Form 4
+10.00%
1.63K
—
—
17.98K
May 17
Form 4
+10.81%
1.59K
—
—
16.35K
May 19
Form 4
+14.21%
1.84K
—
—
14.75K
May 20
Form 4
+29.16%
2.92K
—
—
12.92K
May 20
Form 3
—
0
—
—
0
No matching records found

Coley Pharmaceutical Group, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 4
Form 4
—
0
—
—
0
Jun 14
Form 4
—
0
—
—
0
Jun 21
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

Biohaven Pharmaceutical Holding Co Ltd. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.90K
$148.50
-$430,650.00
0
Oct 3
Form 4
—
0
—
—
0
Apr 28
Form 4
—
0
—
—
0
Dec 20
Form 4
—
0
—
—
0
May 5
Form 4/A
—
0
—
—
0
Jun 9
Form 3/A
—
0
—
—
0
Form 4
—
0
—
—
0
Jun 9
Form 3
—
0
—
—
0
No matching records found

Allergan plc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.29K
—
—
0
May 8
Form 4
-32.46%
-2.06K
$189.74
-$391,623.36
4.29K
May 1
Form 4
+54.26%
1.86K
$146.17
$269,826.12
5.29K
Apr 30 - May 2
Form 4
+14.20%
426
$139.07
$59,243.82
3.43K
Feb 18
Form 3
—
0
—
—
0
No matching records found